![]() |
![]() |
The European Fee’s Well being Emergency Preparedness and Response Authority, HERA, will procure and donate 175,420 doses of the MVA-BN® vaccine, the one FDA and EMA-approved mpox vaccine, as a right away response to the mpox outbreak in Africa. As well as, the pharmaceutical firm Bavarian Nordic will donate 40,000 doses to HERA. The Africa CDC will distribute the vaccines in response to regional wants.
By the Africa CDC, these vaccines will probably be distributed to affected international locations. Moreover, HERA is in collaboration with the Africa CDC with the purpose to develop entry to mpox diagnostics and sequencing within the area, with a €3.5 million grant foreseen for early autumn.
Africa CDC declared on 13 August a Public Well being Emergency of Continental Safety, to answer the escalating public well being concern throughout the area. Africa CDC has known as upon the worldwide group to assist its efforts in mobilising 2 million vaccines, a name to which HERA has responded instantly.
Background
MVA-BN or Modified Vaccinia Ankara-Bavarian Nordic is a non-replicating smallpox vaccine and the one mpox vaccine authorized within the EU/EEA and United Kingdom (marketed as IMVANEX®). US and Switzerland (marketed as JYNNEOS®), and in Canada (marketed as IMVAMUNE®). MVA-BN has been indicated to be used within the common grownup inhabitants (18 years and older) in people thought-about in danger for smallpox or mpox.
At the moment, solely two African international locations have granted Emergency Use Authorization for the MVA-BN vaccine, however the WHO final week requested Bavarian Nordic to submit an Expression of Curiosity for Emergency Use Itemizing (EUL) of the vaccine, which might speed up its accessibility to African international locations the place nationwide regulatory approvals aren’t but in place.
HERA has labored with Bavarian Nordic for the reason that 2022 mpox outbreak, initially by way of direct procurement agreements, adopted by the signing of a joint procurement settlement which has enabled EU member states and extra international locations within the European Financial Space (EEA) in addition to Western Balkan international locations to acquire the mpox vaccine for nationwide use.
Extra Info

“Robust international partnerships are on the very core of our European Well being Union. Well being safety threats know no borders and at the moment, due to the collaboration between the European Fee, Africa Centre for Illness Management and Bavarian Nordic, we make 215,000 vaccines out there to guard probably the most susceptible in international locations affected by the outbreak of mpox in Africa. Preparedness and response to well being threats is a worldwide endeavour which we’re decided to pursue collectively and with solidarity throughout borders.”
Well being and Meals Security Commissioner Stella Kyriakides
“We’re grateful for the swift and beneficiant response from the European Fee and Bavarian Nordic to the mpox outbreak. The donation of over 215,000 doses, is a vital step in our struggle in opposition to this disaster. This partnership not solely delivers important vaccines but additionally underscores our collective dedication to safeguarding well being throughout Africa. It exemplifies the facility of worldwide collaboration in addressing public well being emergencies. Collectively, we’ll strengthen our response efforts and be certain that communities throughout the continent obtain the safety they want.”
Dr. Jean Kaseya, director common of the Africa Centres for Illness Management and Prevention